Basic fibroblast growth factor shows prognostic impact on survival in operable non-small cell lung cancer patients

about

Clinical benefit from EGFR-TKI plus ginsenoside Rg3 in patients with advanced non-small cell lung cancer harboring EGFR active mutation.

P2860

Q37688567-9C890616-55F2-4060-8698-9BCBE7CC7AB1

P2860

Basic fibroblast growth factor shows prognostic impact on survival in operable non-small cell lung cancer patients

Item

http://www.wikidata.org/entity/Q35879398

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Basic fibroblast growth factor ...... mall cell lung cancer patients

@ast

Basic fibroblast growth factor ...... mall cell lung cancer patients

@en

type

Item

label

Basic fibroblast growth factor ...... mall cell lung cancer patients

@ast

Basic fibroblast growth factor ...... mall cell lung cancer patients

@en

prefLabel

Basic fibroblast growth factor ...... mall cell lung cancer patients

@ast

Basic fibroblast growth factor ...... mall cell lung cancer patients

@en

P1476

Basic fibroblast growth factor ...... mall cell lung cancer patients

@en

P2093

Bao-Lan Li

http://www.w3.org/2001/XMLSchema#string

Guang-Kuo Gao

http://www.w3.org/2001/XMLSchema#string

Guang-Li Shi

http://www.w3.org/2001/XMLSchema#string

Ming-Ming Hu

http://www.w3.org/2001/XMLSchema#string

Yi Han

http://www.w3.org/2001/XMLSchema#string

Ying Hu

http://www.w3.org/2001/XMLSchema#string

P2860

FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCepsilon, B-Raf and S6K2

Fibroblast growth factor (FGF) and FGF receptor-mediated autocrine signaling in non-small-cell lung cancer cells

Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.

Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis

Inhibition of fibroblast growth factor 2-induced apoptosis involves survivin expression, protein kinase C alpha activation and subcellular translocation of Smac in human small cell lung cancer cells.

Rapidly acquired resistance to EGFR tyrosine kinase inhibitors in NSCLC cell lines through de-repression of FGFR2 and FGFR3 expression.

Anti-angiogenesis therapies: their potential in cancer management

Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels.

P304

450-457

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1759-7714.12202

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

270052925

http://www.w3.org/2001/XMLSchema#string

P698

26273400

http://www.w3.org/2001/XMLSchema#string

P932

4511323

http://www.w3.org/2001/XMLSchema#string

Basic fibroblast growth factor shows prognostic impact on survival in operable non-small cell lung cancer patients

about

P2860

P2860

Basic fibroblast growth factor shows prognostic impact on survival in operable non-small cell lung cancer patients

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932